Nektar Therapeutics (NKTR) Stock News
$NKTR · NASDAQ · 10 stories in 30 days$36.00
1D −4.56%1W −5.53%1M −41.73%
BORSA has published 10 stories on Nektar Therapeutics (NKTR) in the past 30 days. BORSA’s news read on NKTR is bullish at 60/100, +2 over 24 hours, based on 4 company events over the past 7 days. NKTR last closed at $41.17 on Oct 9, down 5.53% over five sessions and down 41.73% over the past month. Nektar Therapeutics’ next earnings report is scheduled for Thursday, Nov 5.
The wire on $NKTR
newest first · updated · direct subject stories onlyUBS initiates coverage on Nektar Therapeutics with a Neutral rating
UBS has initiated coverage on Nektar Therapeutics.
neutral 50 · impact 20
